Improving Biodistribution Studies for Neurological Gene Therapies

Time: 1:05 pm
day: Pre-Conference Workshop Day


Understanding biodistribution in gene therapies for the CNS is holding back many therapies from regulatory approval and commercialisation so presents itself as an area in dire need for better understanding.

In this workshop session, join experts in bioanalytics and biodistribution to uncover recent bioanalytical advancements in animal models to build sufficient biodistribution data to apply within your own development for your gene therapy neurological products.

This session will include:

  • Improving understandings how to undertake biodistribution studies on mice, rat, or non-human primate models for CNS gene therapies
  • Advancing the analytical methods used for preclinical biodistribution assessments in Neurological disorders
  • Improving access to non-human primate models as the best template for biodistribution assessments in Europe